227 related articles for article (PubMed ID: 28963538)
1. Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling.
Rahnamoun H; Lu H; Duttke SH; Benner C; Glass CK; Lauberth SM
Nat Commun; 2017 Sep; 8(1):754. PubMed ID: 28963538
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4.
Rahnamoun H; Hong J; Sun Z; Lee J; Lu H; Lauberth SM
J Biol Chem; 2018 Aug; 293(34):13234-13246. PubMed ID: 29954944
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells.
Weisz L; Damalas A; Liontos M; Karakaidos P; Fontemaggi G; Maor-Aloni R; Kalis M; Levrero M; Strano S; Gorgoulis VG; Rotter V; Blandino G; Oren M
Cancer Res; 2007 Mar; 67(6):2396-401. PubMed ID: 17363555
[TBL] [Abstract][Full Text] [Related]
5. NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53.
Choi Y; Kim JK; Yoo JY
Mol Oncol; 2014 May; 8(3):642-55. PubMed ID: 24518302
[TBL] [Abstract][Full Text] [Related]
6. p53 and NF-κB coregulate proinflammatory gene responses in human macrophages.
Lowe JM; Menendez D; Bushel PR; Shatz M; Kirk EL; Troester MA; Garantziotis S; Fessler MB; Resnick MA
Cancer Res; 2014 Apr; 74(8):2182-92. PubMed ID: 24737129
[TBL] [Abstract][Full Text] [Related]
7. p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
Pappas K; Xu J; Zairis S; Resnick-Silverman L; Abate F; Steinbach N; Ozturk S; Saal LH; Su T; Cheung P; Schmidt H; Aaronson S; Hibshoosh H; Manfredi J; Rabadan R; Parsons R
Mol Cancer Res; 2017 Aug; 15(8):1051-1062. PubMed ID: 28483946
[No Abstract] [Full Text] [Related]
8. Control of p53-dependent transcription and enhancer activity by the p53 family member p63.
Karsli Uzunbas G; Ahmed F; Sammons MA
J Biol Chem; 2019 Jul; 294(27):10720-10736. PubMed ID: 31113863
[TBL] [Abstract][Full Text] [Related]
9. Acute TNF-induced repression of cell identity genes is mediated by NFκB-directed redistribution of cofactors from super-enhancers.
Schmidt SF; Larsen BD; Loft A; Nielsen R; Madsen JG; Mandrup S
Genome Res; 2015 Sep; 25(9):1281-94. PubMed ID: 26113076
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional cross talk between NF-kappaB and p53.
Webster GA; Perkins ND
Mol Cell Biol; 1999 May; 19(5):3485-95. PubMed ID: 10207072
[TBL] [Abstract][Full Text] [Related]
11. Cooperative interactions between p53 and NFκB enhance cell plasticity.
Bisio A; Zámborszky J; Zaccara S; Lion M; Tebaldi T; Sharma V; Raimondi I; Alessandrini F; Ciribilli Y; Inga A
Oncotarget; 2014 Dec; 5(23):12111-25. PubMed ID: 25401416
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells.
Li J; Wang K; Chen X; Meng H; Song M; Wang Y; Xu X; Bai Y
BMC Mol Biol; 2012 Jan; 13():4. PubMed ID: 22292433
[TBL] [Abstract][Full Text] [Related]
13. Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature.
Solomon H; Buganim Y; Kogan-Sakin I; Pomeraniec L; Assia Y; Madar S; Goldstein I; Brosh R; Kalo E; Beatus T; Goldfinger N; Rotter V
J Cell Sci; 2012 Jul; 125(Pt 13):3144-52. PubMed ID: 22427690
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
[TBL] [Abstract][Full Text] [Related]
15. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress.
Wu H; Lozano G
J Biol Chem; 1994 Aug; 269(31):20067-74. PubMed ID: 8051093
[TBL] [Abstract][Full Text] [Related]
16. Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells.
Wu CC; Yu CT; Chang GC; Lai JM; Hsu SL
Biochem Biophys Res Commun; 2011 Feb; 405(2):168-72. PubMed ID: 21216229
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor-NFκB complex formation is required for progesterone-induced NFκB nuclear translocation and binding onto the p53 promoter.
Hsu SP; Yang HC; Kuo CT; Wen HC; Chen LC; Huo YN; Lee WS
Endocrinology; 2015 Jan; 156(1):291-300. PubMed ID: 25353185
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
Cui Y; Guo G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
[TBL] [Abstract][Full Text] [Related]
19. Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells.
Hamilton KE; Simmons JG; Ding S; Van Landeghem L; Lund PK
Mol Cancer Res; 2011 Dec; 9(12):1718-31. PubMed ID: 21994466
[TBL] [Abstract][Full Text] [Related]
20. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.
Rahnamoun H; Lee J; Sun Z; Lu H; Ramsey KM; Komives EA; Lauberth SM
Nat Struct Mol Biol; 2018 Aug; 25(8):687-697. PubMed ID: 30076409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
